Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)

NCT00684567 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

RADIATION: Radiotherapy
DRUG: Temozolomide

Sponsor

Merck Sharp & Dohme LLC